Kan Wang

Kan Wang is a researcher in the Department of Epidemiology at Erasmus MC, Rotterdam, actively contributing to population health and cardiometabolic disease research. With a recent doctoral thesis completed in 2023, Kan Wang is emerging as a key contributor in precision epidemiology and public health sciences.

Research Interests: Kan Wang's work focuses on the interplay between metabolic and cardiovascular health, particularly in the context of diabetes (including Maturity Onset Diabetes of the Young), obesity subclassification, and glycemic control. Additional interests span genetic risk factors, heart rate variability, and health disparities, including transgender health in Chinese populations. The research leverages large-scale cohort data such as the UK Biobank and employs advanced methods like Mendelian randomization and qualitative analysis.

The publication record shows a strong trend toward precision medicine and risk stratification in cardiometabolic diseases, with recent articles in Nature Medicine and The Journal of Clinical Endocrinology and Metabolism, indicating high-impact contributions. Topics range from obesity phenotyping to atrial fibrillation risk and gender-affirming care, demonstrating both breadth and depth in epidemiological inquiry.

Scientific Awards:

• No awards mentioned in the provided text.

Advising and Grants: There is no explicit information about students advised or grants received. However, Kan Wang's role as a PhD graduate and active researcher suggests involvement in collaborative research projects, likely funded through institutional or national grants at Erasmus MC.

Labs and Teams: Kan Wang is part of the broader research network in the Department of Epidemiology at Erasmus MC, collaborating with leading researchers such as M. Kavousi, M. Ikram, and D. Rizopoulos. The work is embedded in large population-based studies, indicating participation in major epidemiological consortia and data-driven research teams.